These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8377719)

  • 1. [Detection of lupus anticoagulants in the routine blood coagulation laboratory exemplified by 36 patients with systemic lupus erythematosus].
    Halbmayer WM; Haushofer A; Schratzberger W; Petera P; Duschet P; Fischer M
    Med Klin (Munich); 1993 Jul; 88(7):417-22. PubMed ID: 8377719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus].
    Alper G; Tavmergen EN; Ozsan H; Tavmergen E; Gümüsdis G; Onat T; Erlacin E
    Zentralbl Gynakol; 1992; 114(10):509-12. PubMed ID: 1414067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
    Mader R; Ziporen L; Mader R; Neumann L; Buskila D
    Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lupus anticoagulants in patients with systemic lupus erythematosus].
    Matsuura Y; Nawata Y; Miike S; Hiraguri M; Kita Y; Kurasawa K; Takabayashi K; Oh H; Iwamoto I; Saito Y
    Ryumachi; 1996 Feb; 36(1):16-24. PubMed ID: 8711533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory diagnosis of lupus anticoagulant].
    Swadźba J; Musiał J; Jankowski M; Bednarczyk M; Dyczek A; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):359-62. PubMed ID: 9273219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
    Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.
    Brandt JT; Triplett DA; Alving B; Scharrer I
    Thromb Haemost; 1995 Oct; 74(4):1185-90. PubMed ID: 8560433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.